Sven Wehrwein is Director of AtriCure, Inc.. Currently has a direct ownership of 28,973 shares of ATRC, which is worth approximately $1.04 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 7,788 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29K
0% 3M change
36.76% 12M change
Total Value Held $1.04 Million

SVEN WEHRWEIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Grant, award, or other acquisition
-
7,788 Added 21.19%
28,973 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
3,186 Added 13.07%
21,185 Common Stock
May 25 2022
BUY
Grant, award, or other acquisition
-
3,564 Added 16.53%
17,999 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
1,749 Added 10.81%
14,435 Common Stock
May 03 2021
SELL
Open market or private sale
$779,700 $77.97 p/Share
10,000 Reduced 44.08%
12,686 Common Stock
May 03 2021
BUY
Exercise of conversion of derivative security
$99,750 $19.95 p/Share
5,000 Added 22.04%
17,686 Common Stock

Also insider at

SPSC
SPS COMMERCE INC Technology
PRLB
Proto Labs Inc Industrials
SW

Sven Wehrwein

Director
Minneapolis, MN

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC